Molecular Cancer Therapeutics Cancer Epigenetics Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

About Molecular Cancer Therapeutics

Molecular Cancer Therapeutics (ISSN Pending) is published once a month, one volume/year (with the exception of Volume 1, which begins with the November 2001 issue and concludes with the December 2002 issue), by the American Association for Cancer Research, Inc. (AACR), 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404. Telephone:
1-866-423-3965 (Toll Free) or (215) 440-9300; Fax (215) 440-9354; E-mail: pubs{at}aacr.org.

Scope: Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

The journal is printed on acid-free paper in the U.S.A.

Address editorial correspondence to: Daniel D. Von Hoff, M.D., Editor-in-Chief, AACR Publications Dept., 615 Chestnut St., 17th Floor Philadelphia, PA 19106-4404. Telephone: 1-866-423-3965 (Toll Free) or (215) 440-9300; Fax (215) 440-9354; E-mail: pubs{at}aacr.org. See Instructions for Authors for manuscript submission information.

Subscriptions: For subscription information, click here.

Back Issues and Single Copy Sales:

NORTH AMERICAN OFFICE

[For U.S., Mexican and Canadian Subscribers]

Turpin Distribution, Ltd
'The Bleachery'
143 West Street
New Milford, CT 06776
860.350.0041
860.350.0039 [fax]
turpinna@turpin-distribution.com

EUROPEAN OFFICE
[For all other Subscribers]

Turpin Distribution, Ltd
Pegasus Drive, Stratton Business Park
Biggleswade
Bedfordshire SG18 8TQ
UK
044-(01) 1767-604.951
044-(01)1767-601.640 [fax]
custserv@turpin-distribution.com

As long as supplies permit, single copies of Molecular Cancer Therapeutics will be sold at $30 per copy for regular and Supplement issues [$50 for institutions], plus $4 shipping for orders outside the U.S.

Advertising representative: M. J. Mrvica Associates, Inc., 2 West Taunton Avenue, Berlin, NJ 08009. Telephone: (856) 768-9360. Fax: (856) 753-0064. Advertisement insertion orders and copy must be received approximately 5 weeks prior to the date of the issue in which the advertisement is to be published. The journal is mailed at the end of the first week of each month.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.